CoChat

Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease

Kadir, Ahmadul, Andreasen, Niels, Almkvist, Ove, Wall, Anders, Forsberg, Anton, Engler, Henry, Hagman, Göran, Lärksäter, Marie, Winblad, Bengt, Zetterberg, Henrik, Blennow, Kaj, Långström, Bengt, Nordberg, Agneta · 2008 · Annals of Neurology
Cited by 133

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Objective: The effects of (−)‐phenserine (phenserine) and placebo/donepezil treatment on regional cerebral metabolic rate for glucose (rCMRglc) and brain amyloid load were investigated by positron emission tomography in 20 patients with mild Alzheimer's disease in relation to cerebrospinal fluid (CSF) and plasma biomarkers, and cognitive function. Methods: The first 3 months of the study was a randomized, double‐blind, placebo‐controlled phase, during which 10 patients received phenserine (30mg/day) and 10 patients the placebo. Three to 6 months was an open‐label extension phase, during which the placebo group received donepezil (5mg/day) and the phenserine group remained on phenserine. After 6 months, all patients received phenserine treatment up to 12 months. The patients underwent positron emission tomography examinations to measure rCMRglc (18 F‐FDG) and amyloid load (11 C‐PIB) at baseline and after 3 and 6 months of the treatment. Neuropsychological and biomarker data were collected at the three times of positron emission tomography imaging. Results: Statistically significant effects on a composite neuropsychological test score were observed in the phenserine‐treated group compared with the placebo and donepezil group at 3 and 6 months, respectively. Values of rCMRglc were significantly increased in several cortical regions after 3 months of phenserine treatment, compared with baseline, and correlated positively with cognitive function and CSF β‐amyloid 40 (Aβ40). Cortical Pittsburgh Compound B retention correlated negatively with CSF Aβ40 levels and the ratio Aβ/β‐secretase–cleaved amyloid precursor protein. In CSF, Aβ40 correlated positively with the attention domain of cognition. Interpretation: Phenserine treatment was associated with an improvement in cognition and an increase in rCMRglc. Ann Neurol 2008

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.21345

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 133

Metadata

Authors
Kadir, A., Andreasen, N., Almkvist, O., Wall, A., Forsberg, A., Engler, H., Hagman, G., Lärksäter, M., Winblad, B., Zetterberg, H., Blennow, K., Långström, B., & Nordberg, A.
Venue
Annals of Neurology
Publisher
Wiley
Published
2008-05
Volume
63
Issue
5
Pages
621-631
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W2051827059
Cited by
133
References
10
FWCI
11.86
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease. https://app.cochat.ai/papers/10.1002/ana.21345
The paper
Kadir, A., Andreasen, N., Almkvist, O., Wall, A., Forsberg, A., Engler, H., Hagman, G., Lärksäter, M., Winblad, B., Zetterberg, H., Blennow, K., Långström, B., & Nordberg, A. (2008). Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease. Annals of Neurology. https://doi.org/10.1002/ana.21345

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.